Solvay has launched a fourth growth platform, complementing existing ones in battery materials, green hydrogen and thermoplastic composites. This will focus on developing sustainable products for multiple markets using renewable feedstocks and biotechnology.

Through its own venture capital fund of Solvay Ventures, Solvay has made an unspecified investment in US-based DMC (Dynamic Metabolic Control) Biotechnologies. The $34-million Series B funding round also included Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures and Michelin.